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Abstract
Purpose – The latest novel coronavirus disease 2019 (COVID-19) pandemic continues to have a significant social
and financial impact globally. It is very essential to study, categorize and systematize published research on
mitigation strategies adopted during previous pandemic scenario that could provide an insight into improving the
current crisis. The goal of this paper is to systematize and identify gaps in previous research and suggest potential
recommendations as a conceptual framework from a strategic point of view.
Design/methodology/approach –A systematic review of Scopus andWeb of Science (WoS) core collection
databaseswas performed based on strict keyword search selections followed by a bibliometricmeta-analysis of
the final dataset.
Findings –This study indicated that the traditional mitigation techniques adopted during past pandemics are
in place but are not capable of managing the transmission capability and virulence of COVID-19. There is a
greater need for rethinking and re-engineering short and long-term approaches to prevent, control and contain
the current pandemic situation.
Practical implications – Integrating various mitigation approaches shall assist in flattening the pandemic
curve and help in the long run.
Originality/value – Articles, conference proceedings, books, book chapters and other references from two
extensive databases (Scopus andWoS) were purposively considered for this study. The search was confined to
the selected keywords outlined in the methodology section of this paper.
Keywords Novel coronavirus, COVID-19, Bibliometric analysis, Systematic review
Paper type Review
Introduction
Global pandemics provoke and disperse potential risks of short-term and long-term fiscal
harm prompting healthcare systems to find newer and stronger coping strategies and
techniques. The nature of the morbidity and mortality of a pandemic can lead to serious
economic disruption and disaster if individual nations do not come upwith a strong collective
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wild animals have been the primary cause of recent pandemics, largely due to increased
animal to human interactions [2, 3]. However, zoonotic pathogens take time to associate and
infect humans, but a few intermittent events of spillover have led to localized outbreaks due to
mutated strains that are capable of searching a human host [4]. Hence, every such organism
generates a spark and spread risk that depends on the population, poverty level, trade and
travel, health systems and other environmental factors specific to each region [1,5].
Previous pandemic encounters
Around 20–50 million people succumbed to the 1918 influenza pandemic that devastated the
world with its long-term consequences. Failure in containing the outbreak, political
mismanagement and manipulated media coverage were the major mistakes that failed
humanity in the past [1]. Influenza viruses can transmit from human to human with ease and
create a severe global pandemic, unlike H5N1, Nipah and Ebola that caused only regional
epidemics [6]. Previously, severe acute respiratory syndrome (SARS) (2002–2003) andMiddle
East respiratory syndrome (MERS) (2012) outbreaks were first transmitted from bats via
palm civets (Guangdong Province) and dromedary camels (Saudi Arabia), respectively. They
caused lower respiratory tract disease along with fever and cough often ending up in relying
on supportive respiratory care and assistance. Moreover, SARS was responsible for 8096
cases and 774 deaths across 29 different countries [7].
Origin of the novel coronavirus–2019
The coronavirus disease 2019 (COVID-19) was reported to have emerged from a fish market
in Wuhan City (Hubei Province), China, where there are speculations about the illicit trade of
wildlife meat [8]. As of the end ofMarch 30, 2020, there were a total of 634,835 confirmed cases
and 29,957 deaths globally [9]. The intensity and rubrics of fecal-oral transmissions in
COVID-19 are yet to be evaluated but were found to exceed the intensity of the SARS
outbreak [10]. The WHO officially declared COVID-19 as a pandemic when the number of
outbreaks spread to more than 110 countries, with between 116,000 and 120,000 confirmed
cases and more than 4,000 deaths and is still believed to have the potential to reach
exacerbated levels of transmission and economic crisis. Within three months (i.e, March 30 –
June 23, 2020), 9,098,970 positive cases and 471,519 deaths were reported. As of June 23, 2020,
the United States of America was leading the list with 2,363,825 positive cases and 122,292
deaths followed by Brazil (1,086,990 cases/50,659 deaths), Russia (592,280 cases/ 8,206
deaths) and India (430,708 cases/ 13,780 deaths) [11].
There is an urgent need to adopt strategic approaches to overcome the damage posed by
this pandemic and we must learn from the different mitigation strategies suggested during
past pandemics to gain insights into curbing and containing the present COVID-19 crisis.
This paper provides a systematic review and bibliometric analysis of previous research work
on pandemic mitigation strategies. At the end of this paper, a conceptual framework from a
strategic point of view is projected to show a step-by-step integrated mitigation protocol.
Furthermore, this paper also aims to cover, review and report on the considerable research
publications on COVID-19 that have been published recently.
Literature review
Preventive measures during pandemic
Interconnected trading networks and teeming cities have made our globe richer but insecure.
However, the focus on strengthening public health and hygiene to stop intermittent
outbreaks and create situational awareness has become the fundamental idea pushing




workers [12,13]. Key defense steps include tracking and tracing transmissions, mass testing,
social distancing and vaccine formulation [14–16]. Countries with lower financial indexes
have considerable difficulty in emulating others in compliance with the norms of the World
Health Organization (WHO) in the development of infectious disease monitoring, crisis
management and risk communication systems [1].
Importance of pandemic preparedness
Preparing for a pandemic is a challenge due to a multitude of causes, many of which are
similar to natural disasters. Pandemics are unusual occurrences, and the probability of
occurrence is affected by anthropogenic changes in the natural environment. Besides, there is
widespread responsibility for preparedness, but most countries at greatest risk have
restricted capacity to handle and minimize the risk of a pandemic [17]. Pandemic outbreaks
cannot be confined within a consigned geographic boundary. Strong and rapid domestic and
global preparedness is required to stop the spread and spark risk. An integrated approach by
public health agencies, professional personnel, relevant government officials and political
leaders is necessary to achieve optimum situational awareness and cost-effective
outcomes [18,19].
Economic and social impact
Recurring recent events are diminishing the budget allocated to healthcare systems. The
scarcity of medical equipment and medication has become a major issue. People in the hot
zone are under extreme mental stress as a result of intensified government warnings,
lockdown laws and stocks/services deficit leading to insecure demographic alterations in
social life [20,21]. The mortality rate of the current COVID-19 pandemic is unpredictable and
the containment of the spread is very difficult due to the sheer transmission capability of this
pathogen. The fiscal recession and social impact is inevitable and unpredictable in this
current pandemic [22,23].
Reproductive index or transmission curve of COVID-19
COVID-19 differs epidemiologically from SARS-CoV. It replicates efficiently in the upper
respiratory tract and appears to cause a less abrupt onset of symptoms, similar to conventional
human common colds. In contrast, in SARS-CoV most transmission is said to have occurred
when infected individuals are presented with severe illness, thus possibly making it easier to
contain the outbreaks [24–26]. There is a great difference in the reproduction number (R0)
between the two. The R0 number is the average number of secondary cases produced by the
standard infectious case or, in otherwords, the transmissionparameter of that particular disease.
The median value of R0 during 1918 was 1.80 (interquartile range [IQR]: 1.47–2.27). The median
R0-value for 2009was 1.46 (IQR: 1.30–1.70) [27]. Reproduction number, R0, of 2019-nCoV keeping
in mind the intrinsic growth rate (Δ) and the serial intervals (SI) of two other well-known
coronavirus diseases,MERS andSARS, as approximations, shows a predominantly exponential
increase that varies from 2.24 (95% CI: 1.96–2.55) to 3.58 (95% CI: 2.89–4.39) consistent with an
2 to 8-fold rise in the reporting rate showing the ability of 2019-nCoV to trigger larger
outbreaks [28].
Methodology
The systematic review aims to collect all applicable information that reports extensively on
current literature and replies to relevant research gaps. Efforts to eliminate bias in the
detection, collection, synthesis and description of studies have been undertaken in this study.





for the review [29]. Both Scopus and Web of Science (WoS) core collection databases were
considered where they covered most of the articles published in PubMed and the COVID-19
database. The search was strictly executed with the keywords “Pandemic”, “COVID-19” and
“Strategy”.
The search code for Scopus database was – (TITLE (pandemic) OR TITLE (COVID-19)
AND TITLE-ABS-KEY (strategy) AND TITLE-ABS-KEY (strategies)) AND
PUBYEAR > 2009, generating 761 entries and WoS core collection database was –
TOPIC: (COVID-19) OR TOPIC: (pandemic) AND TOPIC: (strategy) OR TOPIC:
(strategies) timespan: 2009-2020. Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH, BKCI-S, BKCI-SSH, ESCI, generating 270 entries. The past ten years of literature were
selected for the search (2010–2020). A total of 1031 entries that were acquiredwere screened
for duplicates. The search results included journal articles, conference proceedings, books
and other sources (book chapters). After clearly reading the title and abstract of all the
entries a total of 927 entries were finalized to initiate this study. The whole dataset was
selected for the review to eliminate bias in the detection, collection, synthesis and
description of the collected dataset. After a detailed systematic review, a bibliometric
analysis of the dataset was carried out to understand the relevance and link strengths
between keywords and researchers. The entire dataset was first screened to obtain the
keyword and co-author citation burst under certain criteria to get the optimal view. The
criteria or parameters were set by the authors manually to avoid keyword repetitions and
project only impactful research work with good relevance and linkage strengths which is
clearly explained in the bibliometric section. The method as suggested by Vandenberg et al.
[30] is adapted in this study shown in Figure 1.
Results
This section addresses the publishing pattern, publication type, language, publishing source,
percentage of keywords usage, past and present strategic interventions and a conceptual
framework. A bibliographic analysis of keyword clusters and co-author citations was







Hellewell et al. [31] (1) Highly efficient communication (tracing and tracking)
Ng et al. [32] (1) Prolonged monitoring techniques (fast detection and isolation)
(2) Effective surveillance suppressing proliferation
Wang et al. [33] (1) Healthcare staff training
(2) Replenishing medical equipment




(1) 60% reduction in transmission if quarantined within 1 day from the onset of
symptoms
(2) Social distancing set based on the stringent degree of pragmatism
Huh et al. [35] (1) Dedicated walk-in-clinic, training for medical workers, specialized infrastructure,
transport and test and retest, integrated surveillance and intensive testing (drive-
through), case isolation, strict visitor controls, exchange and disinfect PPE, social




(1) Combination of national emergency planning with centers for infectious disease
control
(2) Disease surveillance and detection and treatment
(3) Community engagement
(4) Public hygiene stations and gears
Berger et al. [37] (1) Free testing, School and university closures, food, shelter, residency and safety to
the public, improve employment rights, reimburse sick leave
Wong et al. [38] (1) Increasing medical facility to manage patients, visitors and staff
(2) Improved communication between staff—hybrid communication channels












extracted from the overall analysis of the literature. The reporting on pandemic outbreaks
and approaches from 2011 to 2019 has decreased significantly. Ninety-five percent of the
material was in the form of journal articles and around 880 sources are written in the English
language. A random selection of the top 20 keywordswas chosen after a detailed review of the
title and abstract of the 927 papers, and the percentage of their usage in the dataset was
calculated. Some keywords in blue text as shown in Figure 2 had a lower percentage usage.
For example, keywords such as “prevention”, “security”, “environment” and “preparedness”
were less used and were lacking in research studies.
Table 1 discusses the selective mitigation strategies proposed by previous researchers.
The British Medical Journal reports 43 publications followed by PLOS One, Vaccine and
BMC Public Health and Infectious Disease, Human Vaccines and Immunotherapeutics,
Influenza and Other Respiratory Viruses, the Lancet and Clinical Infectious Diseases that
have 35, 34, 28, 19, 13, 12 and 10 publications, respectively.
Table 1 reports strategies from past and present pandemic scenarios. The insights from
Table 1 suggest new ideas and feasibilities. Since the preparation of the vaccine and trial checks
are time consuming, a series of integrated non-clinical strategies are needed when core clinical
interventions like medications, vaccine trials and intensive healthcare fail. An information
technology-based approach that registers, traces and tracks positive cases canhelpnations build
government-based application platforms to restrict the mobility of positive cases from the hot
zone and also create better vigil in safe zones. Moreover, the transmission capacity of this
COVID-19 is very highand requires strategically plotted patient arrivals, PPEusage,work shifts
for staffs, funeral services, flexible and robot automated intensive care units, mass testing, e-
healthcare, circular medical logistics, e-grocery, mobile clinics, movement control orders,
effective financial policy, dedicated communication platforms and advanced training to the
medical personnel. A cumulative set of all these strategic suggestions are put together to draw
frameworks and are further detailed in the discussion section of this paper.
Bibliometric analysis
All keywords co-occurrence
The entire collection of 927 articles was fed into the bibliometric application to test run the
keyword set, which in turn showed the strong relevance of the different research work [39].
Initially, 4991 keywords were present and keywords that reached a limit of 20 repetitions or
above were only considered when they met requirement protocol.
Four keyword clusters were obtained after omitting the duplicates and plurals. Each
clusterwas designated a color and the keywords nodal burst represented a high percentage of
linkage showing its proximity and the percentage of connectivity in each cluster. Keywords
such as “Disease Control” “Disease Outbreak”, “Epidemic”, “Human”, “Influenza” and
“Pandemic” from cluster 1, “H1N1 Influenza”, “Vaccination”, “Influenza Vaccine” and
“Controlled Study” from cluster 2, “Adult”, “Adolescent”, “Age factors”, “Infant” and “School”
from Cluster 3 and “Cross-sectional study” from cluster 4 were considered. Every cluster was
created by its strength and proximity or relevance. Unattended topics or research areas were
displayed with nodal projections with smaller diameters and farther away from the center.
Many of them were invisible due to the very small amount of research conducted in those
areas that are related to those respective keywords.
To explain a few, topics such as “Health Care Personnel”, “Isolation and Purification
Strategies”, “Attitude” and “knowledge on healthcare” from the perspective of a pandemic
scenario, have still not been extensively studied. Similarly, in Cluster 1, topics such as
“Disaster Planning”, “Morbidity”, “Infection Control” and “Decision Making”; “Infection Risk
Factors” based on age, gender and “Location of the Population” in Cluster 3; “Drug Efficacy”




directly correlate with the problems faced in this current pandemic (COVID-19). The keyword
nodal burst is shown in Figure 3.
Researcher co-citation Scopus and WoS
The relation and proximity between the previous researchers and their work were retrieved
with the co-citation nodal burst. The total number of researchers was approximately 3591 in
the entire Scopus collection where the minimum number of papers per author was fixed at 3
that gave 115 as the final number. Similarly, theWoS database of 270 entrieswas selected and
the keywords “mitigation” or “strategies” or both together in title, abstract and keywords
section were searched. A total of 467 authors were obtained which was further scrutinized to
47 by including the criteria (i.e. each researcher should have been cited at least once). A nodal
burst of co-citation of researchers shows the linkage and impactful research collaborations as
shown in Figure 4.
Conceptual strategic framework
After a thorough review and examination of existing literature, the authors of this paper have
developed a set of logically integrated conceptual protocols and projected them as a
framework that places great emphasis on contingency approaches that should be followed to
address the current crisis. The framework outlined in Figure 5 shows an integrated strategy
that recommends an organized approach to improvement, cloud-based tracing and tracking
framework, dedicated healthcare protocol and offshore medical rigs.
Discussion
After a detailed categorization and cumulative accumulation of insights gained from this









Figure 5a is an integrated step-by-step protocol for monitoring and controlling any pandemic
related issues, commencing with the preparedness protocol that mainly focusses on risk
assessment and containment measures. If the nation has struggled in the first phase, it could
follow the monitoring and treatment protocol focusing primarily on the testing, monitoring
and tracking measures adopted, followed by healthcare and treatment as shown in Figure 5a.
In addition, during this recession period, new fiscal-policy measures must come into play. For
example, loan buyers have been greatly hit during this recent COVID-19 pandemic and are in
dire need of loan waivers and liquidity programs [40].
For effectivemitigation, healthcare integrated with cloud-basedmedical analytics capable
of measuring the outbreak role index (ORI) should be sought to provide better support and
flexibility [41]. The mobile healthcare supported by the Internet of things (IoT) platform is an
effective way to incorporate the system of this sort [42]. Remote continuous monitoring of
patients suggested by Sareen et al. [43] based on radio frequency identification device (RFID),
wearable sensor technology and cloud computing infrastructure was previously effective in
detecting andmonitoring Ebola-infected patients [44]. In Figures 5a and b suggestion for this



























complexities. A dedicated QR code should be allocated to each user, registered with the cloud
software application. Applicants with positive and negative test results can be categorized
and given different color codes (i.e. positive, negative and symptomatic) during targetedmass
population screenings. Later, with this information, travel restrictions can be imposed in
vulnerable zones along with strict legal actions as stated by Rolston [45]. Nevertheless, the
healthcare community should come upwithmobile clinics, doorstepmedical assistance and e-
grocery service to the worst-hit clusters in an effort to stop their physical movement.
Furthermore, to avoid an outbreak within the medical community, protecting and
safeguarding healthcare staff, PPE usage and replacement should be a top priority [35].
Proper usage of PPE, strictly following the guidelines for PPE usage and disposal, could save
resources in PPE utilization [46]. Mobilizing personal protective equipment at the time of
crisis is very difficult [47]. Hence, there is a stringent need for a modern and technically better
way of transferring patients, replenishing surgical supplies, preadmission protocols, testing/
transport, post-discharge procedures, setting up dedicated medical centers and monitoring
smart medical logistics. To address this and neatly project the idea, the authors suggest a
protocol to identify, transport, receive, manage and treat COVID-19 positive cases as detailed
in Figure 5c.
In addition, artificial intelligence and smart algorithms are needed to build an anti-
transmission and detection system such as face recognition and thermal screening in public
areas [48,49]. Moreover, wide monitoring and detection in the areas of positive clusters will
ease social isolation, diagnosis and care [50–52]. An e-provisional store for the online
purchase of essential medical items and related logistics services to deliver them safely to
hospitals and households can restrict humanitarian movement.
Moreover, there is a shortage of hospital beds and medical equipment. Licina [53]
suggested that offshore ships that are converted into hospitals are a possible option, but this
cannot be used indefinitely to solve the problem, nor does inclusion of other indoor arenas.
Onshore or inland countermeasures will permanently overload healthcare facilities due to the
unprecedented rate of positive cases and spread risks. The authors suggest an innovative and
feasible long-term solution to this major problem, such as offshore rigs with specialized
medical and testing laboratories as shown in Figure 5d. These proposed offshoremedical rigs
should ideally be a sophisticated state of the art facility especially dedicated to pandemic
situations and can be utilized for multiple causes on a long-term basis. They should be
designed to hold hybrid testing labs, research facilities, PPE storage warehouses, dedicated
dorms for medics, secure logistics routes and patient beds. Even though this is an expensive
option, it may be possible with collective international funds, upgraded citizen tax policies,
initiatives from private/government health organizations and superpower nations like the
USA and Germany. This could prove very effective on a long-term basis giving birth to the
new notion called “The Green Countries”. Countries with very minimal or no positive cases
enjoy this status and can open up borders for the other green nations.
Future directions
Readiness for the long-term fight. The spark can only be curbed by imposing strict global
regulations on adverse dietary habits that include zoonotic animals [54]. Countrywide off
seasonal periodic checks are essential to monitoring spark risk [55]. For constant and
continued diagnosis and effective surveillance, countermeasures are needed in the long run to
keep a check on Influenza-Like Illness (ILI) [56,57]. Community-centered treatment is an
important criterion to be noted rather than patient-centered treatment and the world
healthcare associations need to have a long-term strategy [58]. The global community should
prepare responsive long-term strategies, especially for pandemic outbreaks. A series of





guidelines. Efforts to learn more about the characteristics of this COVID-19 should be carried
out by reviewing uncharted arenas and provide a unique window of interventions.
Improvising technological measures
Technological advancements in the medical field have met the quality standards but they lag
in quantity during huge pandemic outbreaks [59]. Economically feasible medical packages
should meet the same quality and become the main agenda of the companies that
manufacture medical aids and equipment [60]. Moreover, effective and cost-effective
healthcare strategies should be developed without compromising quality [61].
Conclusion
Rigorous and continued social distancing is critical at this moment. However, tight isolation
and containment of COVID-19 patients, in particular, may prove to be a difficult task in the
long run. Nonetheless, these are the only robust mitigation methods currently adopted [62].
Moreover, this is not just a matter of medical treatment and intensive care as the involvement
and collaboration of social scientists, epidemiologists, engineering specialists, psychologists
and social workers are required [58]. Rethinking and redesigning the mitigation strategies to
handle this current crisis is crucial.
Data on other normal health issues should be corroborated with pandemic related
databases. To do so, adopting advanced monitoring systems (e-healthcare analytics) that can
help monitor citizen’s health conditions based on person-related data can be sought. The
results of this study show that very little research has been done in the area of COVID-19
mitigation strategies such as factors influencing PPE production, distribution and usage,
automated intensive care setup, patient handling, social and healthcare sustainability
protocols. More research should focus on the area of pandemic spark assessment and prior
containment strategies rather than only limiting the masses to social distancing and self-
containment. Circular healthcare business models, medical reverse logistics, PPE reuse/
disposal protocols, non-conventional semi-automated medical facilities, healthcare
humanitarian logistics, sustainable medical supply chains and innovative governmental
backup requires further in-depth research. To conclude, these strategic protocols can only be
successful if it is feasible for all populations across various countries from the standpoint of
adaptability and cost issues. Pandemics such as COVID-19 indicate possibilities in
undiscovered mutated viral strains and pathogens that can still cause further outbreaks.
A long-term strategy should always be in place to meet another viral pandemic.
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